Pharmaceutical composition for treating lupus nephritis comprising thalidomide

摘要

The present invention relates to a pharmaceutical composition comprising thalidomide or lenalidomide for coadministration for preventing or treating adrenal disorders. The amount of albuminuria is significantly reduced in a lupus nephritis animal model by using the pharmaceutical composition for preventing and treating adrenal disorders according to the present invention, and thus, the composition of the present invention exhibits an effect for treating and preventing lupus nephritis.